- Home
- ONCY vs AIXI Comparison
ONCY vs AIXI Comparison
Compare ONCY & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- AIXI
- Stock Information
- Founded
- ONCY 1998
- AIXI 2001
- Country
- ONCY Canada
- AIXI China
- Employees
- ONCY N/A
- AIXI N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- AIXI Computer Software: Prepackaged Software
- Sector
- ONCY Health Care
- AIXI Technology
- Exchange
- ONCY Nasdaq
- AIXI Nasdaq
- Market Cap
- ONCY 53.6M
- AIXI 43.9M
- IPO Year
- ONCY 1999
- AIXI 2023
- Fundamental
- Price
- ONCY $0.56
- AIXI $4.19
- Analyst Decision
- ONCY Strong Buy
- AIXI
- Analyst Count
- ONCY 4
- AIXI 0
- Target Price
- ONCY $4.00
- AIXI N/A
- AVG Volume (30 Days)
- ONCY 224.8K
- AIXI 63.6K
- Earning Date
- ONCY 03-07-2025
- AIXI 04-29-2025
- Dividend Yield
- ONCY N/A
- AIXI N/A
- EPS Growth
- ONCY N/A
- AIXI N/A
- EPS
- ONCY N/A
- AIXI N/A
- Revenue
- ONCY N/A
- AIXI $65,643,604.00
- Revenue This Year
- ONCY N/A
- AIXI $22.85
- Revenue Next Year
- ONCY N/A
- AIXI $22.70
- P/E Ratio
- ONCY N/A
- AIXI N/A
- Revenue Growth
- ONCY N/A
- AIXI 6.22
- 52 Week Low
- ONCY $0.55
- AIXI $2.06
- 52 Week High
- ONCY $1.53
- AIXI $16.65
- Technical
- Relative Strength Index (RSI)
- ONCY 27.91
- AIXI 48.16
- Support Level
- ONCY $0.58
- AIXI $3.82
- Resistance Level
- ONCY $0.65
- AIXI $4.45
- Average True Range (ATR)
- ONCY 0.03
- AIXI 0.41
- MACD
- ONCY -0.00
- AIXI 0.05
- Stochastic Oscillator
- ONCY 1.34
- AIXI 72.94
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.